Vault-13

5AM Venture Management, LLC

SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2021 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
San Francisco, CA (main office)United States United Statesabout 8
Boston, MAUnited States United States7
New York, NYUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
Senior Research AnalystNew York, NY 1 $350,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$401.4m reported value +2.7% vs Q1 2023
24positions
79.1%in top 10
4 new 3 added 1 reduced 4 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 5,798,475 $118.3m29.48% 29.48% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 5.8m, Q2 2023 5.8m
2 ENTRADA THERAPEUTICS INC COM TRDA TRDA 4,408,379 $66.7m16.63% 16.63% UnchangedShares held: Q3 2022 4.4m, Q4 2022 4.4m, Q1 2023 4.4m, Q2 2023 4.4m
3 DISC MEDICINE INC COM IRON IRON 488,442 $21.7m5.40% 5.40% ReducedShares held: Q3 2022 0, Q4 2022 588.4k, Q1 2023 588.4k, Q2 2023 488.4k -100.0k -100,000 -17.0%
4 RALLYBIO CORP COM COM 3,630,724 $20.5m5.12% 5.12% UnchangedShares held: Q3 2022 3.7m, Q4 2022 3.7m, Q1 2023 3.6m, Q2 2023 3.6m
5 VOR BIOPHARMA INC COM COM 6,361,723 $19.7m4.90% 4.90% UnchangedShares held: Q3 2022 6.4m, Q4 2022 6.4m, Q1 2023 6.4m, Q2 2023 6.4m
6 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 357,486 $18.2m4.54% 4.54% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 38.9k, Q2 2023 357.5k +318.6k +318,630 820.0%
7 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 862,286 $15.5m3.87% 3.87% UnchangedShares held: Q3 2022 862.3k, Q4 2022 862.3k, Q1 2023 862.3k, Q2 2023 862.3k
8 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 490,000 $13.8m3.44% 3.44% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 490.0k
9 SCPHARMACEUTICALS INC COM SCPH SCPH 1,200,647 $12.2m3.05% 3.05% UnchangedShares held: Q3 2022 3.3m, Q4 2022 2.7m, Q1 2023 1.2m, Q2 2023 1.2m
10 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 310,270 $10.5m2.62% 2.62% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 310.3k
11 VIKING THERAPEUTICS INC COM VKTX VKTX 585,000 $9.5m2.36% 2.36% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 350.0k, Q2 2023 585.0k +235.0k +235,000 67.1%
12 COGENT BIOSCIENCES INC COM COGT COGT 790,440 $9.4m2.33% 2.33% UnchangedShares held: Q3 2022 790.4k, Q4 2022 790.4k, Q1 2023 790.4k, Q2 2023 790.4k
13 PHARVARIS N V COM PHVS PHVS 587,600 $8.9m2.22% 2.22% UnchangedShares held: Q3 2022 587.6k, Q4 2022 587.6k, Q1 2023 587.6k, Q2 2023 587.6k
14 ARVINAS INC COM ARVN ARVN 320,000 $7.9m1.98% 1.98% UnchangedShares held: Q3 2022 400.0k, Q4 2022 320.0k, Q1 2023 320.0k, Q2 2023 320.0k
15 AVIDITY BIOSCIENCES INC COM RNA RNA 665,555 $7.4m1.84% 1.84% UnchangedShares held: Q3 2022 390.6k, Q4 2022 665.6k, Q1 2023 665.6k, Q2 2023 665.6k
16 ANAPTYSBIO INC COM ANAB ANAB 357,733 $7.3m1.81% 1.81% UnchangedShares held: Q3 2022 0, Q4 2022 357.7k, Q1 2023 357.7k, Q2 2023 357.7k
17 MIRATI THERAPEUTICS INC COM MRTX MRTX 192,500 $7.0m1.73% 1.73% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 192.5k
18 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 280,000 $6.7m1.66% 1.66% UnchangedShares held: Q3 2022 484.9k, Q4 2022 300.0k, Q1 2023 280.0k, Q2 2023 280.0k
19 SPRUCE BIOSCIENCES INC COM COM 2,364,000 $5.1m1.27% 1.27% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.4m, Q2 2023 2.4m
20 MERSANA THERAPEUTICS INC COM COM 1,305,000 $4.3m1.07% 1.07% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m, Q2 2023 1.3m +120.0k +120,000 10.1%
21 HOMOLOGY MEDICINES INC COM FIXX FIXX 4,535,919 $4.0m1.00% 1.00% UnchangedShares held: Q3 2022 4.5m, Q4 2022 4.5m, Q1 2023 4.5m, Q2 2023 4.5m
22 IMPEL PHARMACEUTICALS INC COM COM 2,884,791 $3.7m0.91% 0.91% UnchangedShares held: Q3 2022 2.9m, Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 2.9m
23 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 152,022 $1.8m0.45% 0.45% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 152.0k
24 CIDARA THERAPEUTICS INC COM COM 1,134,511 $1.3m0.32% 0.32% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
IDEAYA BIOSCIENCES INC IDYA IDYA 868,520 $11.9m868.5k shares
FIBROGEN INC 579,434 $10.8m579.4k shares
IVERIC BIO INC OPHT OPHT 284,626 $6.9m284.6k shares
PEAR THERAPEUTICS INC 16,744,113 $4.3m16.7m shares